137 related articles for article (PubMed ID: 36195623)
1. Treatment outcome and prognostic analysis of advanced large cell neuroendocrine carcinoma of the lung.
Xia L; Wang L; Zhou Z; Han S
Sci Rep; 2022 Oct; 12(1):16562. PubMed ID: 36195623
[TBL] [Abstract][Full Text] [Related]
2. Prognostic nomogram predicts overall survival in pulmonary large cell neuroendocrine carcinoma.
He Y; Liu H; Wang S; Chen Y
PLoS One; 2019; 14(9):e0223275. PubMed ID: 31560723
[TBL] [Abstract][Full Text] [Related]
3. Risk factors, survival analysis, and nomograms for distant metastasis in patients with primary pulmonary large cell neuroendocrine carcinoma: A population-based study.
Song Z; Zou L
Front Endocrinol (Lausanne); 2022; 13():973091. PubMed ID: 36329892
[TBL] [Abstract][Full Text] [Related]
4. [Development and Validation of A Prognostic Nomogram to Guide Decision-making
in Lung Large Cell Neuroendocrine Carcinoma].
Chen S; Li S; Wang Z; Zhang W; Zhou L; Jiao W
Zhongguo Fei Ai Za Zhi; 2023 Jul; 26(7):487-496. PubMed ID: 37653012
[TBL] [Abstract][Full Text] [Related]
5. Incidence, survival comparison, and novel prognostic evaluation approaches for stage iii-iv pulmonary large cell neuroendocrine carcinoma and small cell lung cancer.
Huang L; Feng Y; Xie T; Zhu H; Tang L; Shi Y
BMC Cancer; 2023 Apr; 23(1):312. PubMed ID: 37020179
[TBL] [Abstract][Full Text] [Related]
6. Risk factors and prognostic factors for pulmonary large cell neuroendocrine carcinoma with brain metastasis.
Chen X; Huang Y; Chen F; She H; Chen X
Cancer Med; 2023 Feb; 12(4):4087-4099. PubMed ID: 36125491
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Nomogram for Overall Survival in Small Cell Lung Cancer Patients Treated with Chemotherapy: A SEER-Based Retrospective Cohort Study.
Liang M; Chen M; Singh S; Singh S
Adv Ther; 2022 Jan; 39(1):346-359. PubMed ID: 34729705
[TBL] [Abstract][Full Text] [Related]
8. Clinical response of large cell neuroendocrine carcinoma of the lung to perioperative adjuvant chemotherapy.
Saji H; Tsuboi M; Matsubayashi J; Miyajima K; Shimada Y; Imai K; Kato Y; Usuda J; Kajiwara N; Uchida O; Ohira T; Hirano T; Mukai K; Kato H; Ikeda N
Anticancer Drugs; 2010 Jan; 21(1):89-93. PubMed ID: 19770636
[TBL] [Abstract][Full Text] [Related]
9. Nomogram predicting overall survival of rectal squamous cell carcinomas patients based on the SEER database: A population-based STROBE cohort study.
Diao JD; Wu CJ; Cui HX; Bu MW; Yue D; Wang X; Liu YL; Yang YJ
Medicine (Baltimore); 2019 Nov; 98(46):e17916. PubMed ID: 31725640
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of nomograms for predicting survival of elderly patients with stage I small-cell lung cancer.
Yang Y; Sun S; Wang Y; Xiong F; Xiao Y; Huang J
Bosn J Basic Med Sci; 2021 Oct; 21(5):632-641. PubMed ID: 33577444
[TBL] [Abstract][Full Text] [Related]
11. Survival Nomogram for Stage IB Non-Small-Cell Lung Cancer Patients, Based on the SEER Database and an External Validation Cohort.
Zuo Z; Zhang G; Song P; Yang J; Li S; Zhong Z; Tan Q; Wang L; Xue Q; Gao S; Sun N; He J
Ann Surg Oncol; 2021 Jul; 28(7):3941-3950. PubMed ID: 33249521
[TBL] [Abstract][Full Text] [Related]
12. A prognostic model of patients with ovarian mucinous adenocarcinoma: a population-based analysis.
Yang L; Yu J; Zhang S; Shan Y; Li Y; Xu L; Zhang J; Zhang J
J Ovarian Res; 2022 Feb; 15(1):26. PubMed ID: 35168642
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Nomograms for Primary High-Grade Glioma Patients in Adult: A Retrospective Study Based on the SEER Database.
Yang Y; Yao M; Long S; Xu C; Li L; Li Y; Li G
Biomed Res Int; 2020; 2020():1346340. PubMed ID: 32775408
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a nomogram for predicting the overall survival of patients with lung large cell neuroendocrine carcinoma.
Xi J; Zhao M; Zheng Y; Liang J; Hu Z; Huang Y; Yang Y; Zhan C; Jiang W; Lu T; Guo W; Wang Q
Transl Cancer Res; 2020 Aug; 9(8):4943-4957. PubMed ID: 35117856
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a nomogram to predict the prognosis of patients with gastric cardia cancer.
Shi X; Xu L; Ma B; Wang S
Sci Rep; 2020 Aug; 10(1):14143. PubMed ID: 32839498
[TBL] [Abstract][Full Text] [Related]
16. A nomogram for predicting survival in patients with advanced (stage III/IV) pancreatic body tail cancer: a SEER-based study.
Shi H; Chen Z; Dong S; He R; Du Y; Qin Z; Zhou W
BMC Gastroenterol; 2022 Jun; 22(1):279. PubMed ID: 35658912
[TBL] [Abstract][Full Text] [Related]
17. Lung Large Cell Neuroendocrine Carcinoma: A Population-Based Retrospective Cohort Study.
Mu X; Pu D; Zhu Y; Zhou Y; Wu Q; Liu Q; Yin L; Li Y
J Clin Med; 2023 Jun; 12(12):. PubMed ID: 37373819
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a SEER-based prognostic nomogram for cervical cancer patients below the age of 45 years.
Liu Q; Li W; Xie M; Yang M; Xu M; Yang L; Sheng B; Peng Y; Gao L
Bosn J Basic Med Sci; 2021 Oct; 21(5):620-631. PubMed ID: 33485294
[TBL] [Abstract][Full Text] [Related]
19. A new nomogram and risk classification system for predicting survival in small cell lung cancer patients diagnosed with brain metastasis: a large population-based study.
Shan Q; Shi J; Wang X; Guo J; Han X; Wang Z; Wang H
BMC Cancer; 2021 May; 21(1):640. PubMed ID: 34051733
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors and predictive models for patients with lung large cell neuroendocrine carcinoma: Based on SEER database.
Li W; Huang Q; He X; He Q; Lai Q; Yuan Q; Deng Z
Clin Respir J; 2024 Apr; 18(4):e13752. PubMed ID: 38606731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
